The non-haematopoietic biological effects of erythropoietin.
about
Systemic VHL gene functions and the VHL diseaseNovel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammationIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesThe erythropoietin receptor is a downstream effector of Klotho-induced cytoprotectionErythropoietin enhances immunostimulatory properties of immature dendritic cellsGene-environment interactions: neurodegeneration in non-mammals and mammalsNonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.Erythropoietin couples hematopoiesis with bone formationOxidative stress: Biomarkers and novel therapeutic pathways.New strategies for Alzheimer's disease and cognitive impairment.Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial.Diabetes mellitus: channeling care through cellular discoveryThe "O" class: crafting clinical care with FoxO transcription factors.Dendritic Cell Dysfunction in Patients with End-stage Renal DiseaseThe role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questionsLower extremity ulcers in systemic sclerosis: features and response to therapy.General anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain.Erythropoietin ameliorates early ischemia-reperfusion injury following the Pringle maneuver.Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival.Macrophages as novel target cells for erythropoietin.The effect of erythropoietin on normal and neoplastic cells.Endogenous and exogenous stem cells: a role in lung repair and use in airway tissue engineering and transplantation.Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study.Erythropoietin and cancer: the unintended consequences of anemia correctionPromises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?Novel avenues of drug discovery and biomarkers for diabetes mellitus.Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trialSurvival and proliferative roles of erythropoietin beyond the erythroid lineage.Hypoxia and fetal heart development.Epigenetic silencing of erythropoietin in human cancersA novel EPO receptor agonist improves glucose tolerance via glucose uptake in skeletal muscle in a mouse model of diabetesThe role of erythropoietin and bone marrow concentrate in the treatment of osteochondral defects in mini-pigs.Protective effect of erythropoietin against myocardial injury in rats with sepsis and its underlying mechanisms.Growth factors in ischemic stroke.Clinical use of erythropoietin in chronic kidney disease: outcomes and future prospects.Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage.Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients.Association of Erythropoietin Dose and Route of Administration with Clinical Outcomes for Patients on Hemodialysis in the United StatesContrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity
P2860
Q24605882-0E70E430-ACF9-418D-BC4C-7E4A33D102C9Q26823386-FE1B0EC3-BFD5-4884-930C-0F0AC785E4DBQ28388335-0E23CCD5-2F4E-4B0D-B0BB-E2104BD2651AQ28565261-BC9A204E-7EA2-4BC9-B725-E9A8C54B5D05Q28583929-1752C074-EAD2-48ED-96BF-498A8EEEAA72Q28750043-2B76F703-3B14-41C5-8271-EC12881C419BQ30483012-2D720CCE-1AB9-4279-9F8F-29CDF5C2622DQ30539892-3A9A3FD8-4F74-4B11-8CFF-F3F7E74D3329Q33594296-9AB04711-0EDA-46F7-9F9E-3AD6AB9BCF97Q33682262-5343ABA8-515A-4442-BFE0-B8A225EF940CQ33717008-390A6D1A-D23A-4B36-B0F8-E96AD9F4BFCDQ33726150-A7B8D371-E6A0-44A8-B295-659F08E9EE3EQ33749358-7B13FFFD-1D2E-4E61-8F06-D09AD5E5B552Q33824809-B5A58921-FF44-48E5-99B3-3C651E596D0FQ33835103-8A13EA32-4762-4D4B-B031-DFF4F6D10660Q34065957-229E6867-DF91-4A43-A671-4B3D97BF4738Q34106172-048F9C64-10A1-4AA4-8AFA-03CA72F794BBQ34117531-C52F37AF-7788-4243-8799-E2FBCAE38282Q34200868-7A129A5E-AE73-442D-A5FE-D31478A20DECQ34202836-C5606B98-981A-4EFF-B9C0-F8D99A310064Q34255067-AADD0C80-DF2D-487C-A3C9-7FAD08DB3602Q34291437-6D62D363-98A4-4C35-A6E8-E72A24D39A40Q34419282-77B11649-0AFD-44D1-8FC6-06A6146965D8Q34433029-BA6EB4ED-2A60-4F8D-A166-A94B530B0DC2Q34488415-A401928E-B6BB-477C-BED8-6FE7A8EEEACFQ34504572-1747EE76-8411-467E-833D-59611C550793Q34552287-05C9898C-C965-45DA-8DC9-1CC8BD574D16Q34663582-40FB2F24-57AE-4665-98CF-8C553FBF7A62Q34725972-C0243675-0D22-46B6-907D-48BD1E95005DQ34788585-F0881B39-AE22-4069-B2C5-4F107047095FQ35034068-15C1D6BC-96E7-49EC-9407-97047DFC578BQ35094217-ECA7FC1B-825F-40E1-B0DE-969864EF8910Q35133620-F38296FA-5F07-4893-8ED9-CD2D0F0F84FAQ35201722-C9305706-7033-47CF-9274-B78540186262Q35216143-028375F7-4A3C-4B95-9731-46FCB3ED1ABDQ35530060-F56046C2-F74B-41B2-9C14-53281435D96AQ35574105-8E9AD984-C58C-49FD-A380-4F35257F3C2BQ36058555-0F58B463-55B6-4B63-ADC2-DFD0DCE8612BQ36123609-DAF46049-938E-4991-9C40-494258C850FBQ36322416-F5483784-45B7-4A1F-A22B-214A92E4CFAC
P2860
The non-haematopoietic biological effects of erythropoietin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The non-haematopoietic biological effects of erythropoietin.
@en
The non-haematopoietic biological effects of erythropoietin.
@nl
type
label
The non-haematopoietic biological effects of erythropoietin.
@en
The non-haematopoietic biological effects of erythropoietin.
@nl
prefLabel
The non-haematopoietic biological effects of erythropoietin.
@en
The non-haematopoietic biological effects of erythropoietin.
@nl
P1476
The non-haematopoietic biological effects of erythropoietin.
@en
P2093
Murat O Arcasoy
P356
10.1111/J.1365-2141.2008.07014.X
P407
P577
2008-04-01T00:00:00Z